PortalPublikationen18F-FDG PET/CT for Staging and Detection of Extramedullary O...

18F-FDG PET/CT for Staging and Detection of Extramedullary Organ Involvement in Chronic Myelomonocytic Leukemia

Standard

18F-FDG PET/CT for Staging and Detection of Extramedullary Organ Involvement in Chronic Myelomonocytic Leukemia. / Derlin, Thorsten; Clauditz, Till Sebastian; Bannas, Peter.

in: CLIN NUCL MED, 22.10.2013.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Derlin, T, Clauditz, TS & Bannas, P 2013, '18F-FDG PET/CT for Staging and Detection of Extramedullary Organ Involvement in Chronic Myelomonocytic Leukemia', CLIN NUCL MED. https://doi.org/10.1097/RLU.0b013e3182a77c99

APA

Derlin, T., Clauditz, T. S., & Bannas, P. (2013). 18F-FDG PET/CT for Staging and Detection of Extramedullary Organ Involvement in Chronic Myelomonocytic Leukemia. CLIN NUCL MED. https://doi.org/10.1097/RLU.0b013e3182a77c99

Vancouver

Derlin T, Clauditz TS, Bannas P. 18F-FDG PET/CT for Staging and Detection of Extramedullary Organ Involvement in Chronic Myelomonocytic Leukemia. CLIN NUCL MED. 2013 Okt 22. https://doi.org/10.1097/RLU.0b013e3182a77c99

Bibtex

@article{b027707e70674a3c87f8cefc45436db7,
title = "18F-FDG PET/CT for Staging and Detection of Extramedullary Organ Involvement in Chronic Myelomonocytic Leukemia",
abstract = "Chronic myelomonocytic leukemia (CMML) is a rare hematologic malignancy characterized by the accumulation of monocytes in the blood and bone marrow, dysplastic hematopoiesis, and potential leukemic involvement of organs. We report a case of leukemic involvement of cervical lymph nodes detected by F-FDG PET/CT. A 53-year-old woman with CMML and newly diagnosed cervical lymphadenopathy underwent whole-body PET/CT for evaluation of extramedullary disease. PET demonstrated marked tracer uptake in cervical lymph nodes. Histopathological evaluation revealed leukemic involvement. F-FDG PET/CT is a valuable tool enabling sensitive staging of CMML, particularly in case of extramedullary organ involvement.",
author = "Thorsten Derlin and Clauditz, {Till Sebastian} and Peter Bannas",
note = "Editorial Material",
year = "2013",
month = oct,
day = "22",
doi = "10.1097/RLU.0b013e3182a77c99",
language = "English",
journal = "CLIN NUCL MED",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",

}

RIS

TY - JOUR

T1 - 18F-FDG PET/CT for Staging and Detection of Extramedullary Organ Involvement in Chronic Myelomonocytic Leukemia

AU - Derlin, Thorsten

AU - Clauditz, Till Sebastian

AU - Bannas, Peter

N1 - Editorial Material

PY - 2013/10/22

Y1 - 2013/10/22

N2 - Chronic myelomonocytic leukemia (CMML) is a rare hematologic malignancy characterized by the accumulation of monocytes in the blood and bone marrow, dysplastic hematopoiesis, and potential leukemic involvement of organs. We report a case of leukemic involvement of cervical lymph nodes detected by F-FDG PET/CT. A 53-year-old woman with CMML and newly diagnosed cervical lymphadenopathy underwent whole-body PET/CT for evaluation of extramedullary disease. PET demonstrated marked tracer uptake in cervical lymph nodes. Histopathological evaluation revealed leukemic involvement. F-FDG PET/CT is a valuable tool enabling sensitive staging of CMML, particularly in case of extramedullary organ involvement.

AB - Chronic myelomonocytic leukemia (CMML) is a rare hematologic malignancy characterized by the accumulation of monocytes in the blood and bone marrow, dysplastic hematopoiesis, and potential leukemic involvement of organs. We report a case of leukemic involvement of cervical lymph nodes detected by F-FDG PET/CT. A 53-year-old woman with CMML and newly diagnosed cervical lymphadenopathy underwent whole-body PET/CT for evaluation of extramedullary disease. PET demonstrated marked tracer uptake in cervical lymph nodes. Histopathological evaluation revealed leukemic involvement. F-FDG PET/CT is a valuable tool enabling sensitive staging of CMML, particularly in case of extramedullary organ involvement.

U2 - 10.1097/RLU.0b013e3182a77c99

DO - 10.1097/RLU.0b013e3182a77c99

M3 - Other (editorial matter etc.)

C2 - 24152630

JO - CLIN NUCL MED

JF - CLIN NUCL MED

SN - 0363-9762

ER -